Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Vasogen Inc. (AMEX:MEW)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Msgs
Recent Events
July 25Conference call: Vasogen Earnings (Q2 2001)
Location
2155 Dunwin Drive, Ontario, L5L 4M1
Mississauga, Canada
Phone: (905) 569-2265
Fax: (905) 569-9231
Email: investor@vasogen.com
Employees (last reported count): 38
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 1%
·Institutional: 12% (12% of float)
(18 institutions)
·Net Inst. Buying: 2.86M shares (+35.52%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Vasogen Inc. is engaged in the development and commercialization of a therapeutic platform technology designed to harness the human immune response to treat disease. Vasogen's lead clinical program, now entering late-stage development, focuses on applying the Company's proprietary immune modulation therapy to the treatment of peripheral arterial disease. Vasogen's immune modulation therapy is also in clinical development for a number of other indications characterized by immune system dysfunction, including psoriasis, congestive heart failure, ischemia/reperfusion injury, chronic lymphocytic leukemia, and graft-versus-host disease. Through collaborations with leading international researchers, Vasogen is also advancing the development of therapeutic interventions for the treatment of additional autoimmune diseases and neurological disorders.
More from Market Guide: Expanded Business Description

Financial Summary
Vasogen Inc. develops and commercializes therapies for immune system modulation for the treatment of cardiovascular, autoimmune and other cell-mediated inflammatory conditions. For the six months ended 5/31/01, the company reported no revenues. Net loss before US GAAP rose 42% to C$6.8 million. Higher loss reflects an increase in professional fees, general and administrative and research and development expenses.
More from Market Guide: Significant Developments

Officers
FY2000 Pay

William Grant
Chairman
--  
David Elsley
Pres, CEO
$290K
William Cochrane
Vice Chairman
--  
Christopher Waddick
Vice-Pres, Fin., CFO, Corp. Sec. and Treasurer
209K
Eldon Smith
Vice-Pres, Scientific Affairs
138K
Dollar amounts are as of 30-Nov-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- AMEX:MEWAs of 31-Aug-2001
Price and Volume
52-Week Low
on 22-Feb-2001
$4.35 
Recent Price$5.25 
52-Week High
on 25-Sep-2000
$10.00 
Daily Volume (3-month avg)12.6K
Daily Volume (10-day avg)18.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-33.9%
52-Week Change
relative to S&P500
-11.3%
Share-Related Items
Market Capitalization$235.4M
Shares Outstanding44.8M
Float44.4M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.53 
Earnings (ttm)-$0.18 
Earnings (mrq)-$0.06 
SalesN/A 
Cash (mrq)$0.38 
Valuation Ratios
Price/Book (mrq)9.89 
Price/EarningsN/A 
Price/SalesN/A 
Income Statements
Sales (ttm)$0 
EBITDA (ttm)-$9.25M
Income available to common (ttm)-$7.72M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsNov 30
Most recent quarter31-May-2001
Management Effectiveness
Return on Assets (ttm)-30.05%
Return on Equity (ttm)-30.86%
Financial Strength
Current Ratio (mrq)17.68 
Debt/Equity (mrq)0 
Total Cash (mrq)$17.2M
Short Interest
As of 8-Aug-2001
Shares Short1,000 
Percent of Float0.0%
Shares Short
(Prior Month)
1,000 
Short Ratio0.17 
Daily Volume6,000 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 31-May-2001);   dollar amounts based on an exchange rate of 1.55 Canadian Dollars/US Dollar

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.